Alx Oncology Holdings Cash Flow-to-Debt Ratio
Alx Oncology Holdings cash flow-to-debt ratio. Alx Oncology Holdings (ALXO) has a Cash Flow-to-Debt Ratio of -0.65x as of June 2026, meaning its operating cash flow of $-16.06 Million could theoretically repay -1% of its total liabilities ($24.63 Million) in one year. See Alx Oncology Holdings (ALXO) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Alx Oncology Holdings (2018–2025)
Cash flow-to-debt ratio of Alx Oncology Holdings from 2018 to 2025. Historical debt coverage capacity for Alx Oncology Holdings across 8 annual periods. Also explore ALXO net assets growth trend to track the company's year-over-year net asset growth rate.
Alx Oncology Holdings Cash Flow-to-Debt Ratio by Year (2018–2025)
Alx Oncology Holdings cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Alx Oncology Holdings . For the full cash flow conversion analysis, see cash flow conversion of Alx Oncology Holdings .
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.54x | $-84.14 Million | $33.06 Million | ▲ +28.7% |
| 2024 | -3.57x | $-121.91 Million | $34.16 Million | ▼ -44.7% |
| 2023 | -2.47x | $-130.36 Million | $52.84 Million | ▼ -19.0% |
| 2022 | -2.07x | $-89.22 Million | $43.02 Million | ▲ +47.8% |
| 2021 | -3.97x | $-68.10 Million | $17.13 Million | ▲ +35.5% |
| 2020 | -6.17x | $-38.29 Million | $6.21 Million | ▼ -374.0% |
| 2019 | -1.30x | $-14.25 Million | $10.95 Million | ▲ +80.2% |
| 2018 | -6.57x | $-13.19 Million | $2.01 Million | — |